TTFields in General Routine Clinical Care in Patients With Pleural Mesothelioma Study
← catalyst calendarNCT05538806 · readout ≤ 499 d
Sponsored by NovoCure Ltd. (industry) · NVCR — their whole pipeline →.
Phase
—
Status
Recruiting
Study type
Observational
Enrollment
198estimated
Sites
23
Countries
Germany, Italy, Netherlands
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2023-08-01 | actual | When the study began enrolling |
| Primary completion | Dec 2027 | estimated | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | Jun 2028 | estimated | The whole study's end, after follow-up |
| First posted | 2022-09-14 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2025-08-22 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Condition
- Pleural Mesothelioma
Intervention
- Device: TTFields
Primary outcome
what the primary-completion date above is the date OFTime from diagnosis of pleural mesothelioma to death of any cause as median overall survival time.
measured 54 Months
Permalink · NVCR's whole pipeline · Catalyst calendar · Every registered study · What changed